Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitomi Yuki

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Chemical Information and Modeling|January 29, 2021
FMODB: The World's First Database of Quantum Mechanical Calculations for Biomacromolecules Based on the Fragment Molecular Orbital MethodDaisuke Takaya, Chiduru Watanabe, Shunpei Nagase, et al.
Journal of Medicinal Chemistry|March 24, 2020
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon CancerFumiyuki Shirai, Anna Mizutani, Yoko Yashiroda, et al.
Journal of Medicinal Chemistry|March 19, 2019
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase InhibitorsFumiyuki Shirai, Takeshi Tsumura, Yoko Yashiroda, et al.
Science Translational Medicine|April 19, 2013
A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivoYoriko Saito, Hitomi Yuki, Mitsuo Kuratani, et al.
Nature Cancer|February 5, 2022
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemiaMari Hashimoto, Yoriko Saito, Ryo Nakagawa, et al.
Nature Communications|December 9, 2022
Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidasesYuya Nishida, Sachiko Yanagisawa, Rikuri Morita, et al.
Nature Communications|December 21, 2022
Author Correction: Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidasesYuya Nishida, Sachiko Yanagisawa, Rikuri Morita, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Chemical Information and Modeling|January 29, 2021
FMODB: The World's First Database of Quantum Mechanical Calculations for Biomacromolecules Based on the Fragment Molecular Orbital MethodDaisuke Takaya, Chiduru Watanabe, Shunpei Nagase, et al.
Journal of Medicinal Chemistry|March 24, 2020
Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon CancerFumiyuki Shirai, Anna Mizutani, Yoko Yashiroda, et al.
Journal of Medicinal Chemistry|March 19, 2019
Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase InhibitorsFumiyuki Shirai, Takeshi Tsumura, Yoko Yashiroda, et al.
Science Translational Medicine|April 19, 2013
A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivoYoriko Saito, Hitomi Yuki, Mitsuo Kuratani, et al.
Nature Cancer|February 5, 2022
Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemiaMari Hashimoto, Yoriko Saito, Ryo Nakagawa, et al.
Nature Communications|December 9, 2022
Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidasesYuya Nishida, Sachiko Yanagisawa, Rikuri Morita, et al.
Nature Communications|December 21, 2022
Author Correction: Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidasesYuya Nishida, Sachiko Yanagisawa, Rikuri Morita, et al.
Pageof 3